List of Refereed Journals published by UGC, New Delhi on 28-03-2017-- AJRC (Sr. No.-1025); AJM (Sr. No.-2497); RJET (Sr. No.-7220); RJPP (Sr. No.- 7232): RJPPD (Sr. No.- 7234); RJPT (Sr. No.-7235) (19-Apr-2017)        | List of Refereed Journals published by UGC, New Delhi on 11-01-2017-- Research Journal of Pharmacy and Technology (Sr. No.-275); Asian Journal of Management (Sr. No.-3986); Asian Journal of Research in Chemistry (Sr. No.-4008); Research Journal of Engineering and Technology (Sr. No.-31787); Research (22-Jan-2017)        |

Journal :   Research Journal of Pharmacy and Technology

Volume No. :   4

Issue No. :  8

Year :  2011

Pages :   1246-1249

ISSN Print :  0974-3618

ISSN Online :  0974-360X


Allready Registrered
Click to Login

Drug Utilization (DU) 90% Study in Burn Population

Address:   Avinash S. Khairnar*, Mangesh S. Bhalerao and Pravin M. Bolshete
University Department of Interpathy Research and Technology, Maharashtra University of Health Science, Nashik (MS) 420 004
*Corresponding Author
DOI No: Not Available

Background: Burn injuries are common in India. The medical community should take steps to improve the rational use of drugs in burn population. Objective: To determine the Drug Utilization (DU) 90% pattern in burn population. Materials and Methods: A prospective cross-sectional study was conducted in burn ward, tertiary health care centre, Nashik in patients aged between 18-60 years and burn percentage >15%. Prescriptions were copied from the day of admission till discharge, death or non compliance of patients. DU 90%, core indicators and Defined Daily Dosage (DDD) were calculated. Result: Average percentage of burn was 61.96%. 31 patients died (62%) and 19 were survived (38%). Mortality rate was 20% in < 40% Total Body Surface Area (TBSA), 33% in 40-60% TBSA, 95% in TBSA >60%. Drug used in percentage was higher for Ringer Lactate (21.57%), Inj. Gentamicin (8.52%), Inj. Rinitidine (8.38%), Inj. Metronidazole (8.25%), Inj. Cefoperazone + Sulbactum (8.24%) and Inj. Ciprofloxacin (5.58%). The DDD% was found highest for Inj. Dexamethasone (23.3%) and lowest for Inj. Cefoperazone + Sulbactum (0.75%). DU 90% includes Inj. Dexamethasone (23.3%), Inj. Adrenaline (15.85%), Inj. Hydrocortisone (14.35%), Tab. Ranitidine (8.41%), Inj. Diclofenac (3.84%), Tab. Folic Acid (3.76%), Inj. Deriphyllin (3.52%), Tab. Diclofenac (3.5%), Inj. Sulbactum (3.01%), Tab. Ciprofloxacin (3%), Tab. Calcium Citrate (2.44%), Inj. Ciprofloxacin (2.32%), Tab. Ferrous Sulphate (2.2%), Inj. Metronidazole (2.16%), Inj.Gentamicin (1.96%). Conclusion: Based on the observations made in this preliminary study (DU90%), there is need of multicentric (including private hospitals) and long duration evaluation with consideration of age, sex, socioeconomic factors to estimate the rational DU pattern in burn population.
Drug Utilization, Burn, DU90%.
Avinash S. Khairnar, Mangesh S. Bhalerao, Pravin M. Bolshete. Drug Utilization (DU) 90% Study in Burn Population. Research J. Pharm. and Tech. 4(8): August 2011; Page 1246-1249.
[View HTML]      [View PDF]

Visitor's No. :   330856